Orchestra Biomed Holdings Inc at Barclays Global Healthcare Conference Transcript
So, good morning, everybody. Very pleased to have with us today David Hochman, Chairman, Chief Executive Officer and founder of Orchestra Bio.
And my name is Matt Miksic. I cover medical devices here at Barclays. So welcome again.
Thanks. Great to be here as always, Matt.
Yeah, well, thanks for coming. So I thought we'd sort of switch things up, I guess, given some of the focus on drug eluding balloons in the coronary this past weekend at CRT and some of the progress you've made in the last 6 to 12 months there. But before we get started, I thought it might just be, it might be helpful for you to give kind of an overview of the. The two programs where you stand so we can kind of get into a little more detail.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
